DISCOVER OUR NEWS
TheraPPI obtains a €300,000 loan from Bpifrance to advance its research programmes and support its growth
TheraPPI obtains a €300,000 loan from Bpifrance to advance its research programmes and support its growth
TheraPPI completes a first closing of Pre-Seed Financing to advance its lead oncology program targeting a novel protein interaction
In addition to non-dilutive financing, TheraPPI completes initial equity financing to develop its lead program targeting ERK/MyD88 interaction
TheraPPI announces publication of preclinical data in Nature Communications, demonstrating the inhibition of ERK/MyD88 interaction as a promising cancer treatment
TheraPPI scientists publish preclinical data in Nature Communications, demonstrating the inhibition of ERK/MyD88 interaction as a promising cancer treatment
TheraPPI Bioscience awarded the French Tech Emergence grant
TheraPPI has been awarded the French Tech Emergence Grant by BPI France in the context of the “Programme France 2030”.
TheraPPI Bioscience awarded reputable French Tech Seed label
The Pouss@LYS consortium has recently given a favorable recommendation on French Tech Seed label to TheraPPI
TheraPPI Bioscience awarded a Fongit Innovation Fund (FIF) seed loan
The Fondation Genevoise pour l’Innovation Technologique has granted a FIF seed loan of CHF100 000 to TheraPPI